CoChat

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria

Tan, Kathryn C. B., Chow, Wing‐Sun, Ai, Victor H. G., Lam, Karen S. L. · 2002 · Diabetes/Metabolism Research and Reviews
Cited by 54

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Microalbuminuria is associated with dysfunction of the vascular endothelium in patients with diabetes mellitus. The objective of the present study was to determine whether treatment with losartan at a dose sufficient to lower urinary albumin excretion was accompanied by an improvement in endothelial function in type 2 diabetic patients with microalbuminuria. Methods: Endothelial function was measured in 80 type 2 diabetic patients with microalbuminuria and 68 non‐diabetic controls using high‐resolution vascular ultrasound. The diabetic patients were randomised to receive either losartan 50 mg daily or placebo in a 6‐month double‐blind study. Urinary albumin excretion and endothelial function were assessed at baseline, 3 and 6 months. Results: Both endothelium‐dependent (p<0.01) and ‐independent vasodilation (p<0.01) were significantly impaired in diabetic patients with or without history of hypertension compared to the non‐diabetic controls. At baseline, the losartan‐ and placebo‐treated groups were comparable in their clinical characteristics. Blood pressure did not change significantly in either group throughout the study. Urinary mean albumin excretion rate (MAER) decreased in the losartan‐treated group (p<0.01) whereas an increase was observed in the placebo group (p<0.05). At 6 months, the losartan‐treated group had significantly lower MAER than the placebo‐treated group [54.5 (58.3) vs 78.5 (100.5) µg/min, p<0.05; median (interquartile range)]. No significant differences were found in endothelium‐dependent or ‐independent vasodilation. Conclusions: Type 2 diabetic patients with microalbuminuria have impaired endothelium‐dependent and ‐independent vasodilation. Treatment with low‐dose losartan is sufficient to reduce microalbuminuria in these patients without alteration in endothelial function and systemic blood pressure. Copyright © 2002 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.255

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 54

Metadata

Authors
Tan, K. C. B., Chow, W., Ai, V. H. G., & Lam, K. S. L.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2002-01
Volume
18
Issue
1
Pages
71-76
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W2064068766
Cited by
54
References
2
FWCI
2.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. https://app.cochat.ai/papers/10.1002/dmrr.255
The paper
Tan, K. C. B., Chow, W., Ai, V. H. G., & Lam, K. S. L. (2002). Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.255

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.